To examine real-world bleeding events in patients with IPF treated with antifibrotics, including those receiving anticoagulants and/or antiplatelet therapy
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Nintedanib (Primary) ; Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- 04 Aug 2020 New trial record
- 30 Jul 2020 Results published in the Drug Safety